Artiva Biotherapeutics Pioneers NK Cell-Based Therapies for Autoimmune Diseases and Cancer
Artiva Biotherapeutics, a clinical-stage biotech company, is pioneering NK cell-based therapies for autoimmune diseases and cancer treatment, with its lead product candidate AlloNK showing promise in ongoing trials.
3 minutes to read